InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Androski Lindsay. Officer active across 1 company, notably Eloxx Pharmaceuticals, Inc.. In total, 2 disclosures have been logged. Activity tracked since 16 October 2024. The latest transaction was disclosed on 24 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations